Login / Signup

The Potential for QT Interval Prolongation with Chronic Azithromycin Therapy in Adult Cystic Fibrosis Patients.

Sean N AvedissianNathaniel James RhodesTien M H NgAdupa P RaoPaul M Beringer
Published in: Pharmacotherapy (2019)
An association between chronic AZM therapy and longer QTc intervals or significant QTc prolongation was not shown.
Keyphrases
  • drug induced
  • cystic fibrosis
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • prognostic factors
  • stem cells
  • risk assessment
  • bone marrow
  • young adults